Antibiotice S.A. (BVB:ATB)

Romania flag Romania · Delayed Price · Currency is RON
2.525
-0.005 (-0.20%)
At close: Oct 8, 2025
-0.20%
Market Cap1.70B
Revenue (ttm)669.82M
Net Income (ttm)87.13M
Shares Out671.34M
EPS (ttm)0.13
PE Ratio19.45
Forward PEn/a
Dividend0.02 (0.81%)
Ex-Dividend DateSep 25, 2025
Volume78,418
Average Volume231,104
Open2.525
Previous Close2.530
Day's Range2.500 - 2.535
52-Week Range1.750 - 3.320
Beta0.19
RSI52.99
Earnings DateNov 20, 2025

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for d... [Read more]

Industry Pharmaceutical Preparations
Founded 1955
Employees 1,357
Stock Exchange Bucharest Stock Exchange
Ticker Symbol ATB
Full Company Profile

Financial Performance

In 2024, Antibiotice's revenue was 688.70 million, an increase of 11.93% compared to the previous year's 615.29 million. Earnings were 102.20 million, an increase of 26.04%.

Financial Statements

News

There is no news available yet.